Platelet glycoprotein IIb/IIIa antagonists in clinical trials for the treatment of coronary artery disease

Amar M Salam, Jassim Al Suwaidi
  • Expert Opinion on Investigational Drugs, November 2002, Informa Healthcare
  • DOI: 10.1517/13543784.11.11.1645

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.11.11.1645

The following have contributed to this page: Dr Jassim Al Suwaidi

In partnership with: